Clinical trial / 2017
Consuming 50 g of quinoa daily for 12 weeks significantly reduced serum triglycerides and the prevalence of metabolic syndrome in overweight and obese adults.
A 12-week randomized controlled trial evaluated the effects of 25 g/d and 50 g/d of quinoa compared with a control group in 50 overweight and obese participants. Body composition, nutrient intake, and total, LDL, and HDL cholesterol were not significantly altered (P > 0.05). In the 50-g quinoa group, mean serum triglycerides dropped significantly from 1.14 to 0.72 mmol/L at 12 weeks (P < 0.05), and metabolic syndrome prevalence fell by 70%. In the 25-g group, metabolic syndrome prevalence decreased by 40% (from n = 7 at baseline to n = 4 at 12 weeks), with no significant triglyceride changes observed in the control or 25-g groups.
- Study type
- Dose-response randomized, controlled, single-blind parallel trial
- Who was studied
- 50 overweight and obese participants
- What was measured
- Body composition, serum lipids, hormones, and nutrient intakes
THE PAPER
Quinoa Seed Lowers Serum Triglycerides in Overweight and Obese Subjects: A Dose-Response Randomized Controlled Clinical Trial.
Navarro-Perez D, Radcliffe J, Tierney A, Jois M. Curr Dev Nutr, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.